VRCA logo

Verrica Pharmaceuticals (VRCA) Cash From Financing

Annual CFF

$74.21 M
+$91.08 M+539.91%

December 31, 2023

Summary

Performance

1-Year Change

+539.91%

3-Year Change

+110.64%

5-Year Change

-25.32%

15-Year Change

+483.48%

VRCA Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

82.54%
VRCA annual cash flow from financing activities is higher than 82.54% of companies in Healthcare sector

High & Low

All-time High

$99.38 M
VRCA annual cash flow from financing activities is currently -25.32% below its historical high of $99.38 million

3-Year Low

-$16.87 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
VRCA previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
VRCA next annual earnings announcement is scheduled for Feb 28, 2025

OtherVRCAcash flowmetrics:

Annual CFI

-$362.00 K
VRCA annual cash flow from investing activities is -$362.00 thousand

Annual CFO

-$38.58 M
VRCA annual cash flow from operations is -$38.58 million

Annual FCF

-$38.94 M
VRCA annual free cash flow is -$38.94 million

Annual CAPEX

$362.00 K
VRCA annual capital expenditures is $362.00 thousand

Quarterly CFF

-$397.00 K
+$243.00 K+37.97%

September 30, 2024

Summary

Performance

3-Month Change

+37.97%

1-Year Change

-100.9%

3-Year Change

-100%

5-Year Change

-100%

VRCA Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

24.43%
VRCA quarterly cash flow from financing activities is higher than 24.43% of companies in Healthcare sector

High & Low

All-time High

$79.44 M
VRCA quarterly cash flow from financing activities is currently -100.50% below its historical high of $79.44 million

3-Year Low

-$16.85 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
VRCA previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
VRCA next earnings announcement is scheduled for Feb 28, 2025

OtherVRCAcash flowmetrics:

Quarterly CFI

-$16.00 K
VRCA quarterly cash flow from investing activities is -$16.00 thousand

Quarterly CFO

-$8.56 M
VRCA quarterly cash flow from operations is -$8.56 million

Quarterly FCF

-$8.57 M
VRCA quarterly free cash flow is -$8.57 million

Quarterly CAPEX

$16.00 K
VRCA quarterly capital expenditures is $16.00 thousand

TTM CFF

-$1.73 M
-$44.44 M-104.04%

September 30, 2024

Summary

Performance

3-Month Change

-104.04%

1-Year Change

-102.32%

3-Year Change

+89.77%

5-Year Change

+89.77%

VRCA TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

19.96%
VRCA TTM cash flow from financing activities is higher than 19.96% of companies in Healthcare sector

High & Low

All-time High

$111.51 M
VRCA TTM cash flow from financing activities is currently -101.55% below its historical high of $111.51 million

3-Year Low

-$16.87 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
VRCA previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
VRCA next earnings announcement is scheduled for Feb 28, 2025

OtherVRCAcash flowmetrics:

TTM CFI

-$254.00 K
VRCA TTM cash flow from investing activities is -$254.00 thousand

TTM CFO

-$59.37 M
VRCA TTM cash flow from operations is -$59.37 million

TTM FCF

-$59.62 M
VRCA TTM free cash flow is -$59.62 million

TTM CAPEX

$254.00 K
VRCA TTM capital expenditures is $254.00 thousand

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

VRCA Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+539.9%-100.9%-102.3%
3 y3 years+110.6%-100.0%+89.8%
5 y5 years-25.3%-100.0%+89.8%

VRCA Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+539.9%-100.9%+97.6%-102.3%+89.8%
5 y5-yearat high+539.9%-100.9%+97.6%-102.3%+89.8%
alltimeall time-25.3%+539.9%-100.5%+97.6%-101.5%+89.8%

Verrica Pharmaceuticals Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2024
-
-$397.00 K(-38.0%)
-$1.73 M(-104.0%)
Jun 2024
-
-$640.00 K(-3.2%)
$42.72 M(-1.3%)
Mar 2024
-
-$661.00 K(+2348.1%)
$43.27 M(-41.7%)
Dec 2023
$74.21 M(-539.9%)
-$27.00 K(-100.1%)
$74.21 M(-0.0%)
Sep 2023
-
$44.04 M(<-9900.0%)
$74.24 M(+456.3%)
Jun 2023
-
-$84.00 K(-100.3%)
$13.35 M(-0.6%)
Mar 2023
-
$30.28 M(>+9900.0%)
$13.43 M(-179.6%)
Dec 2022
-$16.87 M(-150.1%)
$0.00(-100.0%)
-$16.87 M(-0.0%)
Sep 2022
-
-$16.85 M(>+9900.0%)
-$16.87 M(<-9900.0%)
Jun 2022
-
-$1000.00(-94.4%)
$21.00 K(-92.0%)
Mar 2022
-
-$18.00 K(+500.0%)
$263.00 K(-99.2%)
Dec 2021
$33.65 M(-4.5%)
-$3000.00(-107.0%)
$33.65 M(-1.3%)
Sep 2021
-
$43.00 K(-82.2%)
$34.09 M(+0.1%)
Jun 2021
-
$241.00 K(-99.3%)
$34.05 M(+1.0%)
Mar 2021
-
$33.37 M(+7397.8%)
$33.72 M(-4.3%)
Dec 2020
$35.23 M
$445.00 K(>+9900.0%)
$35.23 M(+0.7%)
DateAnnualQuarterlyTTM
Sep 2020
-
$0.00(-100.0%)
$34.99 M(-0.0%)
Jun 2020
-
-$90.00 K(-100.3%)
$34.99 M(-0.9%)
Mar 2020
-
$34.88 M(>+9900.0%)
$35.30 M(+8244.4%)
Dec 2019
$423.00 K(-99.6%)
$204.00 K(+5000.0%)
$423.00 K(+85.5%)
Sep 2019
-
$4000.00(-98.1%)
$228.00 K(-127.1%)
Jun 2019
-
$212.00 K(+6966.7%)
-$840.00 K(-101.1%)
Mar 2019
-
$3000.00(-66.7%)
$78.39 M(-21.1%)
Dec 2018
$99.38 M(+681.3%)
$9000.00(-100.8%)
$99.38 M(-9.2%)
Sep 2018
-
-$1.06 M(-101.3%)
$109.48 M(-1.8%)
Jun 2018
-
$79.44 M(+278.4%)
$111.51 M(+235.6%)
Mar 2018
-
$20.99 M(+107.6%)
$33.23 M(+161.3%)
Dec 2017
$12.72 M(+2533.3%)
$10.11 M(+948.1%)
$12.72 M(+388.3%)
Sep 2017
-
$965.00 K(-16.7%)
$2.60 M(+58.8%)
Jun 2017
-
$1.16 M(+140.2%)
$1.64 M(+240.2%)
Mar 2017
-
$482.00 K
$482.00 K
Dec 2016
$483.00 K
-
-

FAQ

  • What is Verrica Pharmaceuticals annual cash flow from financing activities?
  • What is the all time high annual CFF for Verrica Pharmaceuticals?
  • What is Verrica Pharmaceuticals annual CFF year-on-year change?
  • What is Verrica Pharmaceuticals quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Verrica Pharmaceuticals?
  • What is Verrica Pharmaceuticals quarterly CFF year-on-year change?
  • What is Verrica Pharmaceuticals TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Verrica Pharmaceuticals?
  • What is Verrica Pharmaceuticals TTM CFF year-on-year change?

What is Verrica Pharmaceuticals annual cash flow from financing activities?

The current annual CFF of VRCA is $74.21 M

What is the all time high annual CFF for Verrica Pharmaceuticals?

Verrica Pharmaceuticals all-time high annual cash flow from financing activities is $99.38 M

What is Verrica Pharmaceuticals annual CFF year-on-year change?

Over the past year, VRCA annual cash flow from financing activities has changed by +$91.08 M (+539.91%)

What is Verrica Pharmaceuticals quarterly cash flow from financing activities?

The current quarterly CFF of VRCA is -$397.00 K

What is the all time high quarterly CFF for Verrica Pharmaceuticals?

Verrica Pharmaceuticals all-time high quarterly cash flow from financing activities is $79.44 M

What is Verrica Pharmaceuticals quarterly CFF year-on-year change?

Over the past year, VRCA quarterly cash flow from financing activities has changed by -$44.44 M (-100.90%)

What is Verrica Pharmaceuticals TTM cash flow from financing activities?

The current TTM CFF of VRCA is -$1.73 M

What is the all time high TTM CFF for Verrica Pharmaceuticals?

Verrica Pharmaceuticals all-time high TTM cash flow from financing activities is $111.51 M

What is Verrica Pharmaceuticals TTM CFF year-on-year change?

Over the past year, VRCA TTM cash flow from financing activities has changed by -$75.97 M (-102.32%)